In addition to weight loss, GLP-1 therapy may reduce circulating insulin and testosterone levels, which can further support hormonal balance and ovulatory function
N Engl J Med (2012) 366:91424
Together, they: Enhance mitochondrial efficiency , ensuring that the body uses fat stores for energy
de Bona Schraiber R, de Mello AH, Garcez ML, de Bem Silveira G, Zacaron RP, de Souza Goldim MP, Budni J, Silveira PCL, Petronilho F, Ferreira GK, Rezin GT (2019) Diet-induced obesity causes hypothalamic neurochemistry alterations in swiss mice
Other considerations include individuals with gastrointestinal issues, as semaglutide may cause nausea, vomiting, or diarrhea, especially during the initial stages of treatment
References Proposed Rule Would Expand Medicare And Medicaid Coverage For Anti-Obesity Medications | Health Affairs CMSs $40B GLP-1 Proposal Offers Leeway for Part D Plans to Define Obe AIS Health - MMIT Medicare & Medicaid Services CMS Proposes Changes to Medicare Adv Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
